Literature DB >> 16265313

Ischemic preconditioning and preinfarction angina in the clinical arena.

Shereif H Rezkalla1, Robert A Kloner.   

Abstract

In animals, brief episodes of ischemia before a total coronary occlusion protect the heart and result in a smaller myocardial infarct size. In humans, episodes of angina before acute myocardial infarction might also confer a preconditioning or protective effect; numerous studies show that preinfarction angina is associated with smaller infarcts. Preinfarction angina is also associated with reductions in ventricular dysfunction, arrhythmias and incidence of no-reflow phenomena, and, in some cases, improved survival. The protective effect of preconditioning in humans is characterized by marked individual variations and seems to be attenuated in women, people with diabetes and the elderly. Exercise seems to be an important way to induce preconditioning in humans and preserves it in the elderly.

Entities:  

Mesh:

Year:  2004        PMID: 16265313     DOI: 10.1038/ncpcardio0047

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  16 in total

1.  Electrocardiographic measures of ventricular repolarization dispersion and arrhythmic outcomes among ST elevation myocardial infarction patients with pre-infarction angina undergoing primary percutaneous coronary intervention.

Authors:  Tarek A N Ahmed; Amr A Abdel-Nazeer; Ayman K M Hassan; Hosam Hasan-Ali; Amr A Youssef
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-02-09       Impact factor: 1.468

Review 2.  Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.

Authors:  Karin Przyklenk
Journal:  Drugs Aging       Date:  2011-05-01       Impact factor: 3.923

Review 3.  Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart.

Authors:  Bartosz Walkowski; Marcin Kleibert; Miłosz Majka; Małgorzata Wojciechowska
Journal:  Cells       Date:  2022-05-05       Impact factor: 7.666

Review 4.  Coronary microvascular dysfunction: an update.

Authors:  Filippo Crea; Paolo G Camici; Cathleen Noel Bairey Merz
Journal:  Eur Heart J       Date:  2013-12-23       Impact factor: 29.983

Review 5.  GLP-1 agonist-based therapies: an emerging new class of antidiabetic drug with potential cardioprotective effects.

Authors:  Melanie Sulistio; Curtis Carothers; Mandeep Mangat; Mike Lujan; Rene Oliveros; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2009-03       Impact factor: 5.113

6.  Protective Effects of Danlou Tablet () against Murine Myocardial Ischemia and Reperfusion Injury In Vivo.

Authors:  Jian-Yong Qi; Lei Wang; Dong-Sheng Gu; Li-Heng Guo; Wei Zhu; Min-Zhou Zhang
Journal:  Chin J Integr Med       Date:  2016-03-21       Impact factor: 1.978

Review 7.  Preconditioning in humans.

Authors:  Shereif H Rezkalla; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

8.  The ischemic preconditioning effect of adenosine in patients with ischemic heart disease.

Authors:  Bita Sadigh; Miguel Quintana; Christer Sylvén; Margareta Berglund; Lars Ake Brodin
Journal:  Cardiovasc Ultrasound       Date:  2009-11-05       Impact factor: 2.062

Review 9.  Cardiovascular remodelling in coronary artery disease and heart failure.

Authors:  Gerd Heusch; Peter Libby; Bernard Gersh; Derek Yellon; Michael Böhm; Gary Lopaschuk; Lionel Opie
Journal:  Lancet       Date:  2014-05-13       Impact factor: 79.321

10.  The bitter fate of the sweet heart: impairment of iron homeostasis in diabetic heart leads to failure in myocardial protection by preconditioning.

Authors:  Vladimir Vinokur; Eduard Berenshtein; Baruch Bulvik; Leonid Grinberg; Ron Eliashar; Mordechai Chevion
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.